Abstract
WuXi Advanced Therapies is the advanced therapies business unit of WuXi AppTec, with a globally integrated, full value chain operational model working to serve clients in the cell and gene therapy sectors. With four sites on three continents, WuXi Advanced Therapies has a presence in the US, China, and the UK, operating as a Contract Testing, Development and Manufacturing Organization (CTDMO).
The company serves as an innovator, with full in-house development and manufacturing capabilities. Its goal is to solve today’s commercialisation challenges by leveraging over 30 years of experience and expertise to deliver the biopharmaceuticals of tomorrow.
Download the resource to continue reading.